search

Rhythm Pharmaceuticals Inc (RYTM)

OverviewChartFinancialsStatisticsEarningsInsider transactionsETFsNews

News

Real-time news feed aggregating press releases, regulatory filings, and global media coverage for a single company, filterable by date range, relevance score, and sentiment classification. Each article is tagged with company-specific and overall market sentiment — allowing investors to separate fundamental catalysts from broader market noise and monitor how the narrative around a stock is evolving over time.

Relevance *
40
RHYTHM Pharmaceuticals CEO David P. Meeker Executes Option Exercise and Sells 50,000 Shares
Sep 16, 2026

RHYTHM Pharmaceuticals CEO David P. Meeker Executes Option Exercise and Sells 50,000 Shares

RHYTHM Pharmaceuticals CEO David P. Meeker exercised options for 50,000 shares at $6.05 each on September 14, 2026, and subsequently sold all 50,000 shares in five transactions ranging from $101.75 to $105.19 per share. After these transactions, Meeker's holdings in RHYTHM PHARMACEUTICALS were 239,258 shares and 15,431 derivative securities. This activity significantly altered his reported ownership, with the exercised shares initially representing 17.3% of his total holdings before the sales.
Company relevance
100.00%
Company sentiment
Neutral
Overall sentiment
Neutral